Literature DB >> 20565694

Cardiopulmonary manifestations of portovenous shunts from congenital absence of the portal vein: pulmonary hypertension and pulmonary vascular dilatation.

Y M Law1, C L Mack, R J Sokol, M Rice, L Parsley, D Ivy.   

Abstract

HPS and PPHTN are unusual and challenging pulmonary manifestations of liver disease. We report two pediatric cases in association with heterotaxy polysplenia syndrome and congenital absence of the portal vein. Both patients were symptomatic and hemodynamically compromised and required aggressive medical therapy. One patient with PPHTN alone achieved a successful liver transplant. The second child presented with combined HPS and PPHTN and exhibited a different evolution of pulmonary vascular disease. These cases illustrate associations that must be entertained in the setting of heterotaxy syndrome, cyanosis, or pulmonary hypertension and how strategic medical combined with surgical management can provide a good outcome.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2010        PMID: 20565694      PMCID: PMC3203339          DOI: 10.1111/j.1399-3046.2010.01355.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  19 in total

1.  Severe portopulmonary hypertension after liver transplantation in a patient with preexisting hepatopulmonary syndrome.

Authors:  G Martinez-Pallí; J A Barberà; P Taurà; I Cirera; J Visa; R Rodriguez-Roisin
Journal:  J Hepatol       Date:  1999-12       Impact factor: 25.083

2.  Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation.

Authors:  Miguel R Arguedas; Gary A Abrams; Michael J Krowka; Michael B Fallon
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-2004. A four-year-old boy with hypoxemia.

Authors:  T Bernard Kinane; Sjirk J Westra
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

4.  Congenital extrahepatic portosystemic shunt associated with heterotaxy and polysplenia.

Authors:  Beverley Newman; Jeffrey A Feinstein; Ronald A Cohen; Brian Feingold; Jacqueline Kreutzer; Hitendra Patel; Fandics P Chan
Journal:  Pediatr Radiol       Date:  2010-01-13

5.  Hypoxemia of cirrhosis: detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method.

Authors:  J D Wolfe; D P Tashkin; F E Holly; M B Brachman; M G Genovesi
Journal:  Am J Med       Date:  1977-11       Impact factor: 4.965

6.  Pulmonary arteriovenous fistulas and polysplenia syndrome.

Authors:  A Amodeo; R Di Donato; A Carotti; B Marino; C Marcelletti
Journal:  J Thorac Cardiovasc Surg       Date:  1994-05       Impact factor: 5.209

7.  Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

Authors:  R C Trembath; J R Thomson; R D Machado; N V Morgan; C Atkinson; I Winship; G Simonneau; N Galie; J E Loyd; M Humbert; W C Nichols; N W Morrell; J Berg; A Manes; J McGaughran; M Pauciulo; L Wheeler
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

8.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.

Authors:  Enid R Neptune; Pamela A Frischmeyer; Dan E Arking; Loretha Myers; Tracie E Bunton; Barbara Gayraud; Francesco Ramirez; Lynn Y Sakai; Harry C Dietz
Journal:  Nat Genet       Date:  2003-02-24       Impact factor: 38.330

9.  Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.

Authors:  Michael J Krowka; M Susan Mandell; Michael A E Ramsay; Steve M Kawut; Michael B Fallon; Cosme Manzarbeitia; Manuel Pardo; Paul Marotta; Shinji Uemoto; Markus P Stoffel; Joanne T Benson
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

10.  Abernethy malformation: one of the etiologies of hepatopulmonary syndrome.

Authors:  Alfonso E Alvarez; Antônio F Ribeiro; Gabriel Hessel; Jamal Baracat; José D Ribeiro
Journal:  Pediatr Pulmonol       Date:  2002-11
View more
  7 in total

Review 1.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

2.  Congenital absence of the portal vein: Define the portosystemic shunt, avoid liver transplantation.

Authors:  Noémie Laverdure; Michel Lallier; Josée Dubois; Massimiliano Paganelli
Journal:  Can Liver J       Date:  2021-08-09

3.  Pediatric liver transplantation using a hepatitis B surface antigen-positive donor liver graft for congenital absence of the portal vein.

Authors:  Jung-Man Namgoong; Shin Hwang; Dae-Yeon Kim; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Kyung Mo Kim; Seak Hee Oh
Journal:  Korean J Transplant       Date:  2021-01-11

Review 4.  Pulmonary vascular complications of liver disease.

Authors:  Jason S Fritz; Michael B Fallon; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2012-11-15       Impact factor: 21.405

5.  Clinical characteristics and therapeutic outcomes of pulmonary arterial hypertension secondary to congenital portosystemic shunts.

Authors:  Jinjin Wu; Yi Lu; Wenzhuo Zhao; Jie Shen; Fen Li; Hao Zhang; Qimin Chen; Lijun Fu
Journal:  Eur J Pediatr       Date:  2020-10-03       Impact factor: 3.183

6.  Congenital absence of the portal vein associated with focal nodular hyperplasia of the liver and congenital heart disease (Abernethy malformation): A case report and literature review.

Authors:  Yabin Hao; Xu Hong; Xinyan Zhao
Journal:  Oncol Lett       Date:  2014-12-04       Impact factor: 2.967

Review 7.  Pulmonary hypertension's variegated landscape: a snapshot.

Authors:  Thomas J Kulik; Eric D Austin
Journal:  Pulm Circ       Date:  2017-03-13       Impact factor: 3.017

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.